[
  {
    "date": "2023-12-30",
    "symbol": "HOTH",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 9292352,
    "prepaidexpenseandotherassetscurrent": 135361,
    "assetscurrent": 9427713,
    "operatingleaserightofuseasset": 55165,
    "investmentsinaffiliatessubsidiariesassociatesandjointventures": 37400,
    "assets": 9520278,
    "accountspayablecurrent": 35592,
    "accruedliabilitiescurrent": 614226,
    "operatingleaseliabilitycurrent": 28839,
    "liabilitiescurrent": 678657,
    "operatingleaseliabilitynoncurrent": 26326,
    "liabilities": 704983,
    "commonstockvalue": 435,
    "additionalpaidincapital": 61732106,
    "retainedearningsaccumulateddeficit": -52944506,
    "accumulatedothercomprehensiveincomelossnetoftax": 27260,
    "stockholdersequity": 8815295,
    "liabilitiesandstockholdersequity": 9520278,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "preferredstocksharesundesignated": 3000000,
    "preferredstocksharesdesignated": 5000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 50000000,
    "commonstocksharesissued": 4348129,
    "commonstocksharesoutstanding": 4348129,
    "researchanddevelopmentexpense": 3480053,
    "generalandadministrativeexpense": 4212189,
    "operatingexpenses": 7692242,
    "operatingincomeloss": -7692242,
    "marketablesecuritiesunrealizedgainloss": -209320,
    "unrealizedgainlossoninvestments": 4400,
    "fairvalueoptionchangesinfairvaluegainloss1": 4400,
    "investmentincomeinterest": 781,
    "dividendincomeoperating": 50991,
    "nonoperatingincomeexpense": -153148,
    "netincomeloss": -7845390,
    "netincomelossavailabletocommonstockholdersbasic": -7845390,
    "earningspersharebasic": -2.3,
    "weightedaveragenumberofsharesoutstandingbasic": 3409190,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 5254,
    "comprehensiveincomenetoftax": -7840136,
    "earningspersharediluted": -2.3,
    "weightedaveragenumberofdilutedsharesoutstanding": 3409190,
    "sharesoutstanding": 4348129,
    "stockissuedduringperiodvaluestockoptionsexercised": 236,
    "stockissuedduringperiodsharesstockoptionsexercised": 2355050,
    "stockissuedduringperiodvalueother": 69,
    "stockissuedduringperiodsharesother": 689275,
    "stockissuedduringperiodvaluesharebasedcompensation": 216428,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 1691,
    "cumulativetranslationadjustmentnetoftaxperiodincreasedecrease": 5254,
    "paymentsofstockissuancecosts": 1575645,
    "gainonterminationoflicenseagreement": 275000,
    "sharebasedcompensation": 216428,
    "gainlossoninvestments": 27000,
    "increasedecreaseinprepaidexpense": 47300,
    "increasedecreaseinaccountspayable": -700752,
    "netcashprovidedbyusedinoperatingactivities": -8447094,
    "proceedfromissuancecommonstockcommonstockwarrantsandprefundedwarrantsnetofo": 11314998,
    "proceedsfromwarrantexercises": 2355,
    "netcashprovidedbyusedinfinancingactivities": 11317353,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -6518,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 2870259,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 9292352,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 59698,
    "emerginggrowthcompanypolicytextblock": "Emerging growthcompany",
    "accountspayablepolicytextblock": "Accounts Payable",
    "scheduleofresearchanddevelopmentexpensesforlicensesacquired": "The following summarizes the Company’s researchand development expenses for licenses acquired during the years ended December 31, 2023 and 2022:",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 4213515,
    "researchanddevelopmentexpenses": 66172,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 1693,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 3.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 1691,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 3.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 2.59,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsweightedaveragevolatilityrate": 1.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0402,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 25289,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 46.1,
    "sharebasedcompensationnumberofsharesoptionsissued": 90000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsissuedinperiodweightedaverageexerciseprice": 2.59,
    "weightedaverageremainingcontractuallifeinyearsemployeeoptionsissued": "P9Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 169362,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 26.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 169362,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 26.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P8Y4M24D",
    "allocatedsharebasedcompensationexpense": 182522,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 4213515,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 7.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P4Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedexercisable": 4212751,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaverageexercisabledatefairvalue": 6.99,
    "weightedaverageremainingcontractuallifeinyearswarrantsexercisable": "P4Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 6165725,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualissued": "P4Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsexercisedinperiod": 2355050,
    "operatingleasecost": 5464,
    "shorttermleasecost": 33351,
    "leasecost": 38815,
    "operatingleaseliability": 55165,
    "proceedsfromleasepayments": 5464,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 32784,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 27320,
    "lesseeoperatingleaseliabilitypaymentsdue": 60104,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 4939,
    "deferredtaxassetsoperatinglosscarryforwards": 11926158,
    "deferredtaxassetscapitallosscarryforwards": 2272029,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 549587,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualslegalsettlements": 266091,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsother": 297949,
    "deferredtaxassetsgross": 15311814,
    "deferredtaxassetsvaluationallowance": 15311814,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.103,
    "effectiveincometaxratereconciliationcredits": 0.008,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": 0.001,
    "effectiveincometaxratereconciliationprioryearincometaxes": -0.002,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.32,
    "entityincorporationdateofincorporation": "2017-05-16",
    "otherresearchanddevelopmentexpense": 100000,
    "compensationexpenseexcludingcostofgoodandservicesold": 2600000,
    "professionalfees": 2500000,
    "paymentsforrent": 100000,
    "othergeneralandadministrativeexpense": 1000000,
    "proceedsfrombankdebt": 100000,
    "interestincomefederalfundssold": 250000,
    "limitedliabilitycompanyllcorlimitedpartnershiplpmembersorlimitedpartnersownershipinterest": 0.03,
    "accountspayableothercurrentandnoncurrent": 260000,
    "costsandexpenses": 29000,
    "licensemaintenancefee": 7500,
    "debtinstrumentfaceamount": 150000,
    "annualminimumpaymentsterm": "P5Y",
    "annualmaintenancefees": 125000,
    "annuallicensemaintenancefee": 2500,
    "yearlyminimumannualroyaltyfee": 5000,
    "assetimpairmentcharges": 400000,
    "sharesissuedpricepershare": 0.17,
    "extendedproductwarrantydescription": "Each December Common Stock Warrant is exercisable for a period of five and one-half years from the issuance date at an exercise priceof $5.00 per share, subject to adjustment, and may, under certain circumstances, be exercised on a cashless basis.",
    "stockissuedduringperiodsharesissuedforservices": 26878,
    "commonstockcapitalsharesreservedforfutureissuance": 66878,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 3000,
    "unrecognizedstockbasedcompensationterm": "P1Y",
    "stockissuedduringperiodvaluestockoptionsexercisednetoftaxbenefitexpense": 200000,
    "operatingleaseweightedaverageremainingleaseterm1": "P1Y9M18D",
    "weightedaverageincrementalborrowingrate": 0.1,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 37700000,
    "federalstateandlocalincometaxexpensebenefitcontinuingoperations": 1500000,
    "operatinglosscarryforwards": 500000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitsemployeebenefits": 2300000,
    "incometaxreconciliationtaxcreditsother": 100000,
    "incometaxreconciliationtaxcredits": 200000,
    "incometaxreconciliationtaxcreditsresearch": 200000,
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityinteractivedatacurrent": "Yes",
    "icfrauditorattestationflag": "false",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "HOTH THERAPEUTICS, INC.",
    "entitycentralindexkey": 1711786,
    "entityfilenumber": "001-38803",
    "entitytaxidentificationnumber": "82-1553794",
    "entityincorporationstatecountrycode": "NV",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityaddressaddressline1": "590 Madison Ave",
    "entityaddressaddressline2": "21st Floor",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 10022,
    "cityareacode": "(646)",
    "localphonenumber": "756-2997",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "HOTH",
    "securityexchangename": "NASDAQ",
    "auditorname": "WithumSmith+Brown, PC",
    "auditorfirmid": 100,
    "auditorlocation": "New York"
  },
  {
    "date": "2022-12-30",
    "symbol": "HOTH",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 6428611,
    "marketablesecurities": 209320,
    "prepaidexpensecurrent": 88450,
    "assetscurrent": 6726381,
    "investmentsinaffiliatessubsidiariesassociatesandjointventures": 33000,
    "assets": 6759381,
    "accountspayablecurrent": 694989,
    "accruedliabilitiescurrent": 667742,
    "accruedlicensefeecurrentportion": 25000,
    "liabilitiescurrent": 1387731,
    "accruedlicensefeenoncurrentportion": 250000,
    "liabilities": 1637731,
    "commonstockvalue": 130,
    "additionalpaidincapital": 50198630,
    "retainedearningsaccumulateddeficit": -45099116,
    "accumulatedothercomprehensiveincomelossnetoftax": 22006,
    "stockholdersequity": 22006,
    "liabilitiesandstockholdersequity": 6759381,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "preferredstocksharesissued": 2000000,
    "preferredstocksharesoutstanding": 2000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 50000000,
    "commonstocksharesissued": 1302113,
    "commonstocksharesoutstanding": 1302113,
    "researchanddevelopmentexpense": 4844578,
    "researchanddevelopmentlicenseacquired": 86586,
    "compensationandrelatedexpensesincludingstockbasedcompensation": 2588595,
    "professionalfees": 2494132,
    "rentexpenses": 66834,
    "othersellinggeneralandadministrativeexpense": 984829,
    "operatingexpenses": 11065554,
    "operatingincomeloss": -11065554,
    "marketablesecuritiesgainloss": -386909,
    "incomelossfromequitymethodinvestments": -377000,
    "interestincomeother": 6370,
    "othernonoperatingincomeexpense": 451140,
    "nonoperatingincomeexpense": -306399,
    "netincomeloss": -11371953,
    "foreigncurrencytranslationadjustment": 4420,
    "comprehensiveincomenetoftax": -11367533,
    "preferredstockdividendsandotheradjustments": -990,
    "netincomelossavailabletocommonstockholdersbasic": -11370963,
    "earningspersharebasic": -9.5,
    "weightedaveragenumberofsharesoutstandingbasic": 1197521,
    "earningspersharediluted": -8.79,
    "weightedaveragenumberofdilutedsharesoutstanding": 1197521,
    "sharesoutstanding": 1302113,
    "stockissuedduringperiodvaluesharebasedcompensation": 620798,
    "stockissuedduringperiodsharessharebasedcompensation": 1801,
    "stockissuedduringperiodvalueother": 5985103,
    "stockissuedduringperiodsharesnewissues": 329412,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 1000,
    "stockissuedduringperiodsharesconversionofunits": 2000000,
    "stockissuedduringperiodvalueconversionofunits": -10,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": -2000000,
    "adjustmentstoadditionalpaidincapitalstocksplit": -1,
    "stockissuedduringperiodsharesreversestocksplits": 11891,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 4420,
    "proceedsfromdebtnetofissuancecosts": 1014896,
    "researchanddevelopmentlicensesacquiredexpensed": 34000,
    "changeinfairvalueofinvestmentsinjointventures": 377000,
    "sharebasedcompensation": 620798,
    "marketablesecuritiesrealizedgainloss": -567692,
    "marketablesecuritiesunrealizedgainloss": 119870,
    "increasedecreaseinprepaidexpense": -3847,
    "increasedecreaseinaccountspayable": 590632,
    "netcashprovidedbyusedinoperatingactivities": -9297854,
    "paymentstoacquireinprocessresearchanddevelopment": 74000,
    "saleofmarketablesecurities": 1235695,
    "netcashprovidedbyusedininvestingactivities": 1161695,
    "proceedsfromissuancecommonstocknetofofferingcost": 5985103,
    "proceedsfromissuanceofpreferredstockandpreferencestock": 1000,
    "proceedsfromissuanceofconvertiblepreferredstock": -10,
    "proceedsfromrepaymentsofnotespayable": 50000,
    "netcashprovidedbyusedinfinancingactivities": 6036093,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -9593,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -2100066,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 6428611,
    "stockissued1": 1,
    "licenseagreementtextblock": "Note 3-License agreements ",
    "notereceivable": "Note 4-Note Receivable ",
    "investmentsinmarketablesecuritiestextblock": "Note 5-Investments in Marketable Equity Securities ",
    "emerginggrowthcompanypolicytextblock": "Emerging growthcompany ",
    "fairvalueoptionnotereceivablepolicytextblock": "Fair Value of Financial Instruments ",
    "scheduleofresearchanddevelopmentexpensesforlicensesacquired": "            For the Years Ended December 31,             2022      2021       The George Washington University     $66,586      $99,782       Isoprene Pharmaceuticals, Inc.      -       15,000       North Carolina State University      27,500       30,000       Virginia Commonwealth University      -       30,000       Chelexa Biosciences, Inc. and the University of Cincinnati      7,500       -       Adjustment      (15,000)      -             $86,586      $174,782    ",
    "scheduleofstockbasedcompensationexpensetabletextblock": "            For the Years Ended December 31,             2022      2021       Employee stock option awards     $560,376      $1,092,428       Employee restricted stock awards      7,836       6,611       Non-employee restricted stock awards      -       124,000       Non-employee stock warrant awards      52,586       99,782             $620,798      $1,322,821    ",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 510875,
    "researchanddevelopmentexpenses": 86586,
    "unrealizedgainlossonderivatives": 119870,
    "realizedinvestmentgainslosses": -567692,
    "dividendincomeoperating": 60913,
    "otherincomenets": -386909,
    "investmentsfairvaluedisclosure": 33000,
    "fairvalueoptionchangesinfairvaluegainloss1": -377000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 3384,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 3.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 5075,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 1791,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 7.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 14.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.961,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.021,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 104651,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 49.8,
    "stockissuedduringperiodsharesemployeestockownershipplan": 51800,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 14.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualissued": 9.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 104651,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 49.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 8.3,
    "weightedaverageremainingcontractuallifeinyearsoutstandingendingbalance": 8.3,
    "allocatedsharebasedcompensationexpense": 620798,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstanding": 402840,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionoutstandingweightedaverageexerciseprice": 49.83,
    "weightedaverageremainingcontractuallifeinyearsoutstandingasofendingbalance": 1.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 401312,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 49.73,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 1.5,
    "deferredtaxassetsoperatinglosscarryforwards": 10378471,
    "capitalizedresearchcosts": 1211477,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 670035,
    "licensesacquired": 338239,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 215152,
    "deferredtaxassetsgross": 12813374,
    "deferredtaxassetsvaluationallowance": 12813374,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.095,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.009000000000000001,
    "equitycompensationindollars": 0.001,
    "rtpandother": 0.1,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.396,
    "aggregategrossproceeds": 10000000,
    "warrantexercisabletermdescription": "The December Wainwright Warrants are exercisable for a period of five and one-half years from the issuance date at an exercise price of$6.25 per share, subject to adjustment, and may, under certain circumstances, be exercised on a cashless basis.",
    "concentrationriskcreditriskfinancialinstrumentmaximumexposure": 250000,
    "limitedliabilitycompanyllcorlimitedpartnershiplpmembersorlimitedpartnersownershipinterest": 0.05,
    "vestingperioddescription": "These options generally vest over a one to five year period",
    "otherexpenses": 53000,
    "licensemaintenancefee": 14000,
    "insurancecommissionsandfees": 28000,
    "annualmaintenancefees": 125000,
    "annualminimumpayment": 150000,
    "annualminimumpaymentsterm": "five years",
    "annuallicensemaintenancefee": 2500,
    "yearlyminimumannualroyaltyfee": 5000,
    "percentageofaccruedinterestrate": 0.06,
    "grossproceeds": 5000000,
    "financingreceivablepurchasedwithcreditdeteriorationamountatpurchaseprice": 15000000,
    "depositliabilitiesaccruedinterest": 50000,
    "supplementaldeferredpurchaseprice": 100000,
    "assetimpairmentcharges": 400000,
    "otherinvestments": 350000,
    "shareprice": 0.15,
    "investmentownedatfairvalue": 33000,
    "preferredstockdesignated": 2000000,
    "stockissuedduringperiodsharesissuedforservices": 51800,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 10000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": 1.45,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 600000,
    "leasesofficespaces": 4500,
    "leaseandrentalexpense": 67000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 300000,
    "interestincomesecuritiestaxable": 65800000,
    "deferredothertaxexpensebenefit": 1500000,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 1200000,
    "employeestockownershipplanesopplandescription": "In general, an ownership change,as defined by Section 382 and 383 of the Code, results from transactions increasing ownership of certain stockholders or public groupsin the stock of the corporation by more than 50 percent points over a three-year period.",
    "entityregistrantname": "Hoth Therapeutics, Inc.",
    "tradingsymbol": "HOTH",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "--12-31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1711786,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2022-12-31",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-38803",
    "entityincorporationstatecountrycode": "Nevada",
    "entitytaxidentificationnumber": "82-1553794",
    "entityaddressaddressline1": "1 Rockefeller Plaza",
    "entityaddressaddressline2": "Suite 1039",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "New York",
    "entityaddresspostalzipcode": 10020,
    "cityareacode": "(646)",
    "localphonenumber": "756-2997",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "auditorname": "WithumSmith+Brown, PC",
    "auditorlocation": "New York",
    "auditorfirmid": 100
  },
  {
    "date": "2021-12-30",
    "symbol": "HOTH",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 8538270,
    "marketablesecurities": 1892837,
    "prepaidexpensecurrent": 93972,
    "notesreceivablerelatedpartiescurrent": 50000,
    "assetscurrent": 10575079,
    "investmentinjointventures": 410000,
    "assets": 10985079,
    "accountspayablecurrent": 360964,
    "accruedliabilitiescurrent": 426823,
    "accruedlicensefeecurrentportion": 80000,
    "liabilitiescurrent": 867787,
    "accruedlicensefeenoncurrentportion": 235000,
    "liabilities": 1102787,
    "commonstockvalue": 2398,
    "additionalpaidincapital": 43589471,
    "retainedearningsaccumulateddeficit": -33727163,
    "accumulatedothercomprehensiveincomelossnetoftax": 17586,
    "stockholdersequity": 17586,
    "liabilitiesandstockholdersequity": 10985079,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 75000000,
    "commonstocksharesissued": 23974546,
    "commonstocksharesoutstanding": 23974546,
    "researchanddevelopmentexpense": 7354708,
    "researchanddevelopmentlicenseacquired": 174782,
    "compensationandrelatedexpensesincludingstockbasedcompensation": 3036034,
    "professionalfees": 2703837,
    "rentexpenses": 46871,
    "otherexpenses": 785208,
    "operatingexpenses": 14101440,
    "operatingincomeloss": -14101440,
    "othernonoperatingincomeexpense": -212265,
    "nonoperatingincomeexpense": -212265,
    "netincomeloss": -14313705,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 32937,
    "comprehensiveincomenetoftax": -14280768,
    "earningspersharebasicanddiluted": -0.64,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 22330093,
    "sharesoutstanding": 23974546,
    "stockissuedduringperiodvalueother": 13407632,
    "stockissuedduringperiodsharesother": 6826962,
    "stockissuedduringperiodvalueissuanceofcommonstockandwarrantsnetofofferingcostsof572500": 4427501,
    "stockissuedduringperiodsharesissuanceofcommonstockandwarrantsnetofofferingcostsof572500": 2475248,
    "stockissuedduringperiodvaluestockoptionsexercised": 359513,
    "stockissuedduringperiodsharesstockoptionsexercised": 1126720,
    "stockissuedduringperiodvaluesharebasedcompensation": 1322821,
    "stockbasedcompensationinshares": 107081,
    "stockissuedduringperiodvaluecumulativetranslationadjustment": 32937,
    "issuanceofcommonstockandwarrants": 572500,
    "issuanceofcommonstockcommonstockwarrantsandprefundedwarrants": 1591600,
    "researchanddevelopmentlicensesacquiredexpensed": 92470,
    "employeebenefitsandsharebasedcompensation": 1322821,
    "marketablesecuritiesrealizedgainloss": -41808,
    "marketablesecuritiesunrealizedgainloss": -176974,
    "foreigncurrencytransactiongainlossunrealized": -59583,
    "increasedecreaseinprepaidexpense": 5420,
    "increasedecreaseinaccountspayable": 535340,
    "netcashprovidedbyusedinoperatingactivities": -12090129,
    "paymentstoacquireinprocessresearchanddevelopment": 116970,
    "purchaseofmarketablesecurities": 2556135,
    "saleofmarketablesecurities": 2507750,
    "netcashprovidedbyusedininvestingactivities": -165355,
    "proceedfromissuancecommonstockcommonstockwarrantsandprefundedwarrantsnetofo": 13407632,
    "proceedsfromissuanceofcommonstockandwarrants": 4427501,
    "proceedsfromissuanceofwarrants": 359513,
    "netcashprovidedbyusedinfinancingactivities": 18194646,
    "effectofexchangerateoncashandcashequivalents": -30562,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 5939162,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 8538270,
    "licenseagreementtextblock": "Note 3—License agreements ",
    "notereceivable": "Note 4—Note Receivable ",
    "investmentsinmarketablesecuritiestextblock": "Note 5—Investments in Marketable Securities ",
    "emerginggrowthcompanypolicytextblock": "Emerging growthcompany ",
    "scheduleofstockbasedcompensationexpensetabletextblock": "            For the years ended December 31,             2021      2020       Employee stock option awards     $1,092,429      $487,963       Non-employee stock option awards      -       100,104       Employee restricted stock awards      6,611       15,510       Non-employee restricted stock awards      124,000       -       Non-employee stock warrant awards      99,782       134,169             $1,322,821      $737,746    ",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 11394777,
    "researchanddevelopmentexpenses": 174782,
    "unrealizedgainlossonderivatives": -176974,
    "realizedinvestmentgainslosses": -41808,
    "dividendincomeoperating": 66101,
    "otherincomenets": -152683,
    "investmentsinaffiliatessubsidiariesassociatesandjointventures": 410000,
    "receivablesfairvaluedisclosure": 50000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 2801,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 10165927,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 107081,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 1.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 2.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.192,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0042,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1321212,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.37,
    "stockissuedduringperiodsharesemployeestockownershipplan": 632000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualissued": 2.3,
    "rfl_sharebasedcompensationarrangementbysharebasedpaymentawardoptionoutstandingweightedaverageremainingcontractualterm2": 8.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 1321212,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 3.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 8.6,
    "allocatedsharebasedcompensationexpense": 1322821,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstanding": 10070764,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionoutstandingweightedaverageexerciseprice": 1.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": -203709,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisedinperiodgross": -1126720,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisedinperiodweightedaverageexerciseprice": 0.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexercised": 2.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 10013495,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 1.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 2.5,
    "currentforeigntaxexpensebenefit": -548660,
    "currentincometaxexpensebenefit": -548660,
    "valuationallowancedeferredtaxassetchangeinamount": -548660,
    "deferredtaxassetsoperatinglosscarryforwards": 6752718,
    "deferredtaxassetsinprocessresearchanddevelopment": 444866,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 590050,
    "licensesacquired": 341171,
    "deferredincometaxassetsdepreciationfixedassets": 72,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 155816,
    "deferredtaxassetsgross": 8284693,
    "deferredtaxassetsvaluationallowance": 8284693,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.08199999999999999,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.018000000000000002,
    "effectiveincometaxratereconciliationtaxcredits": 0.067,
    "equitycompensationindollars": 0.024,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.024,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": 0.003,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.3,
    "effectiveincometaxratecontinuingoperations": 0.038,
    "investmentslimitepercentage": 0.05,
    "marketpriceofgrandexpire": "ten years",
    "optionsofvestoverdescriptoin": "These options generally vest over a one to five year period",
    "relatedwithwarrantsgranted": 100000,
    "totalmilestonepayments": 6000,
    "annuallicensemaintenancefee": 5000,
    "yearlyminimumannualroyaltyfee": 5000,
    "licensefee": 30000,
    "annualmaintenancefees": 30000,
    "annualminimumpayment": 285000,
    "conversionpricedescription": "“Capped Conversion Price”means the lesser of (i) the per share or unit price in the Qualified Financing and (ii) an amount determined by dividing (A) $15 millionby (B) the fully diluted capitalization Isoprene immediately prior to the conversion of the Isoprene Note.",
    "shorttermdebtfairvalue": 50000,
    "preferredstockdesignated": 5000000,
    "stockissuedduringperiodsharesissuedforservices": 632000,
    "warrantstopurchaseofcommonstockshares": 90909,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 2000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": 0.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 1100000,
    "deferredcompensationarrangementwithindividualallocatedsharebasedcompensationexpense": 1100000,
    "leasesofficespaces": 4500,
    "leaseandrentalexpense": 47000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 26700000,
    "interestincomesecuritiestaxable": 22400000,
    "deferredfederalstateandlocaltaxexpensebenefit": 1500000,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": 400000,
    "entityregistrantname": "HOTHTHERAPEUTICS, INC.",
    "tradingsymbol": "HOTH",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1711786,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-38803",
    "entityincorporationstatecountrycode": "Nevada",
    "entitytaxidentificationnumber": "82-1553794",
    "entityaddressaddressline1": "1 Rockefeller Plaza",
    "entityaddressaddressline2": "Suite 1039",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "New York",
    "entityaddresspostalzipcode": 10020,
    "cityareacode": "(646)",
    "localphonenumber": "756-2997",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "auditorname": "WithumSmith+Brown, PC",
    "auditorlocation": "New York, New York",
    "auditorfirmid": 100
  },
  {
    "date": "2020-12-30",
    "symbol": "HOTH",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 2629670,
    "marketablesecurities": 2063236,
    "prepaidexpensecurrent": 89836,
    "assetscurrent": 4782742,
    "receivablenetcurrent": 50000,
    "investmentinjointventures": 410000,
    "assets": 5242742,
    "accountspayablecurrent": 129469,
    "accruedliabilitiescurrent": 128180,
    "accruedlicensefeecurrentportion": 54500,
    "liabilitiescurrent": 312149,
    "accruedlicensefeenoncurrentportion": 285000,
    "liabilities": 597149,
    "commonstockvalue": 1343,
    "additionalpaidincapital": 24073059,
    "retainedearningsaccumulateddeficit": -19413458,
    "accumulatedothercomprehensiveincomelossnetoftax": -15351,
    "stockholdersequity": -15351,
    "liabilitiesandstockholdersequity": 5242742,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 75000000,
    "commonstocksharesissued": 13438535,
    "commonstocksharesoutstanding": 13438535,
    "researchanddevelopmentexpense": 2281363,
    "researchanddevelopmentlicenseacquired": 607562,
    "compensationandrelatedexpensesincludingstockbasedcompensation": 1454478,
    "professionalfees": 2478493,
    "rentexpenses": 25871,
    "otherexpenses": 454207,
    "operatingexpenses": 7301974,
    "operatingincomeloss": -7301974,
    "othernonoperatingincome": 104158,
    "nonoperatingincomeexpense": 104158,
    "netincomeloss": -7197816,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -15351,
    "comprehensiveincomenetoftax": -7213167,
    "earningspersharebasicanddiluted": -0.58,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 12362833,
    "sharesoutstanding": 13438535,
    "issuancecommonstockandwarrantsnetofofferingcost": 4193756,
    "stockissuedduringperiodsharesother": 1449275,
    "issuanceofcommonstocknetofofferingcostsof525000": 4475000,
    "issuanceofcommonstocknetofofferingcostsshares": 1818182,
    "cancellationofcommonstock": 2,
    "stockrepurchasedandretiredduringperiodshares": -15000,
    "warrantexercise": 56250,
    "stockissuedduringperiodshareswarrantexerciseshares": 56250,
    "stockissuedduringperiodvaluesharebasedcompensationgross": 737746,
    "stockissuedduringperiodsharessharebasedcompensationforfeited": 9984,
    "cumulativetranslationadjustmentnetoftaxperiodincreasedecrease": -15351,
    "issuancecommonstockandwarrantsnetofofferingcosts": 806243,
    "issuanceofcommonstocknetofofferingcosts": 525000,
    "depreciation": 1043,
    "researchanddevelopmentlicensesacquiredexpensed": 506957,
    "sharebasedcompensation": 737746,
    "marketablesecuritiesrealizedgainloss": -1177,
    "marketablesecuritiesunrealizedgainloss": 50553,
    "increasedecreaseinprepaidexpense": -20236,
    "increasedecreaseinaccountspayable": -151988,
    "netcashprovidedbyusedinoperatingactivities": -6133198,
    "purchaseofinvestments": -410000,
    "paymentstoacquireinprocessresearchanddevelopment": 167457,
    "purchaseofmarketablesecurities": 2300015,
    "purchaseofconvertiblepromissorynote": 50000,
    "saleofmarketablesecurities": 1089819,
    "netcashprovidedbyusedininvestingactivities": -1837653,
    "proceedsfromissuanceofcommonstockandwarrants": 4193756,
    "proceedsfromissuancecommonstocknetofofferingcost": 4475000,
    "proceedsfromissuanceofwarrants": 56250,
    "netcashprovidedbyusedinfinancingactivities": 8725006,
    "effectofexchangerateoncashandcashequivalents": -15351,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 738804,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 2629670,
    "cancellationandretirementofcommonstock": 2,
    "restrictedcash": 2629670,
    "restrictedcashandcashequivalents": 2629670,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1934360,
    "researchanddevelopmentexpenses": 607562,
    "realizedinvestmentgainslosses": -1177,
    "dividendincomeoperating": 31152,
    "interestincomeoperating": 8,
    "otherincomenets": 80536,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 9882,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 1.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 6666,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 9984,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 0.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 3.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P9Y204D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.145,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0029,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 689212,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P9Y146D",
    "rfl_sharebasedcompensationarrangementbysharebasedpaymentawardoptionoutstandingweightedaverageremainingcontractualterm2": "P8Y292D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 689212,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 4.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y292D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 258824,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualissued": "P4Y328D",
    "gaap_sharebasedcompensationarrangementbysharebasedpaymentawardnonemployeeoptionsissued": 49212,
    "weightedaverageexercisepricenonemployeeoptionsissuedindollars": 2.54,
    "weightedaverageremainingcontractuallifenonemployeeoptionsissued": "P9Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 85000,
    "allocatedsharebasedcompensationexpense": 737746,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstanding": 1235266,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionoutstandingweightedaverageexerciseprice": 3.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentotherthanoptionsaggregateintrinsicvalueoutstanding": 696334,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexercised": "P3Y146D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1158906,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 3.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 696334,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P3Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisedinperiodgross": -56250,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisedinperiodweightedaverageexerciseprice": 1,
    "deferredfederalincometaxexpensebenefit": 1489095,
    "deferredincometaxexpensebenefit": 1489095,
    "valuationallowancedeferredtaxassetchangeinamount": -1489095,
    "deferredtaxassetsoperatinglosscarryforwards": 3336268,
    "deferredtaxassetslicenseacquired": 139487,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 549387,
    "totaldeferredincometaxassets": 4025142,
    "deferredincometaxassetsdepreciationfixedassets": 63,
    "totaldeferredincometax": 63,
    "deferredtaxassetsliabilitiesnet": 4025205,
    "deferredtaxassetsvaluationallowance": 4025205,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": 0.003,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.207,
    "escrowdeposit": 200000,
    "equitymethodinvestmentownershippercentage": 0.05,
    "proceedsfromlicensefeesreceived": 2500,
    "royaltyexpense": 5000,
    "finitelivedpatentsgross": 2000,
    "directtaxesandlicensescosts": 10000,
    "proceedsfromstockoptionsexercised": 20000,
    "adjustmentofwarrantsgrantedforservices": 134000,
    "accruedlicensepayment": 2000,
    "annualminimumpayment": 285000,
    "annualminimumpaymentterm": "P5Y",
    "annualmaintenancefees": 30000,
    "conversionpricedescription": "&#x201c;Capped Conversion Price&#x201d; means the lesser of (i) the per share or unit price in the Qualified Financing and (ii) an amount determined by dividing (A) $15 million by (B) the fully diluted capitalization Isoprene immediately prior to the conversion of the Isoprene Note.",
    "deferredcompensationcashbasedarrangementsliabilitycurrent": 8736,
    "stockrepurchasedduringperiodshares": 35000,
    "preferredstockdesignated": 5000000,
    "conversionofpreferredstocktocommonstockuponcompletionofiposhares": 3102480,
    "purchaseanaggregateshare": 9984,
    "warrantstopurchase": 72464,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 9000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P1Y328D",
    "employeestockownershipplanesopcompensationexpense": 700000,
    "leasesofficespaces": 2500,
    "leaseandrentalexpense": 25000,
    "deferredtaxassetstaxcreditcarryforwards": 15900000,
    "operatinglosscarryforwardslimitationsonuse": "$1.5",
    "descriptionoffuturetaxexpire": "carried forward to future tax years and expire in 2037.",
    "entityregistrantname": "Hoth Therapeutics, Inc.",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "--12-31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1711786,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "entityfilenumber": "001-38803",
    "entityincorporationstatecountrycode": "NV",
    "entityinteractivedatacurrent": "Yes"
  },
  {
    "date": "2019-12-30",
    "symbol": "HOTH",
    "period": "FY",
    "entityregistrantname": "Hoth Therapeutics, Inc.",
    "entitycentralindexkey": 1711786,
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "documenttype": "10-K",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2019,
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityextransitionperiod": "false",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entityfilenumber": "001-38803",
    "entityincorporationstatecountrycode": "NV",
    "cashandcashequivalentsatcarryingvalue": 1690866,
    "marketablesecurities": 803664,
    "prepaidexpensecurrent": 110072,
    "deferredofferingcosts": 30484,
    "assetscurrent": 2635086,
    "propertyplantandequipmentnet": 1043,
    "restrictedcashnoncurrent": 200000,
    "assets": 2836129,
    "accountspayablecurrent": 403885,
    "accruedliabilitiescurrent": 36236,
    "liabilitiescurrent": 440121,
    "liabilities": 440121,
    "commonstockvalue": 1012,
    "additionalpaidincapital": 14610638,
    "retainedearningsaccumulateddeficit": -12215642,
    "stockholdersequity": -12215642,
    "liabilitiesandstockholdersequity": 2836129,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 1897250,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 75000000,
    "commonstocksharesissued": 10119844,
    "commonstocksharesoutstanding": 10119844,
    "researchanddevelopmentexpense": 50000,
    "researchanddevelopmentlicenseacquired": 95000,
    "compensationandrelatedexpensesincludingstockbasedcompensation": 2932933,
    "professionalfees": 2091745,
    "rentexpenses": 31622,
    "otherexpenses": 538577,
    "operatingexpenses": 7714997,
    "operatingincomeloss": -7714997,
    "othernonoperatingincome": 10636,
    "foreigncurrencytransactiongainlossbeforetax": -275,
    "nonoperatingincomeexpense": 10361,
    "netincomeloss": -7704636,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 9164577,
    "earningspersharebasicanddiluted": -0.84,
    "sharesoutstanding": 10119844,
    "conversionofpreferredstocktocommonstockuponcompletionofipo": -310,
    "conversionofpreferredstocktocommonstockuponcompletionofiposhares": -3102480,
    "stockissuedduringperiodvaluenewissues": 5840042,
    "issuancecommonstockiniponetofofferingcostshares": 1250000,
    "issuancecommonstockandwarrantsnetofofferingcost": 1610089,
    "issuancecommonstockandwarrantsnetofofferingcostshares": 407424,
    "stockissuedduringperiodvaluecashlesswarrantexercise": -22,
    "stockissuedduringperiodsharescashlesswarrantexerciseshares": 223877,
    "warrantexercise": 161,
    "stockissuedduringperiodshareswarrantexerciseshares": 16333,
    "stockissuedduringperiodvaluesharebasedcompensationgross": 2495214,
    "stockissuedduringperiodvaluesharebasedcompensationgrossshares": 48330,
    "proceedsfromissuanceinitialpublicoffering": 1159833,
    "issuancecommonstockandwarrantsnetofofferingcosts": 426990,
    "depreciation": 1225,
    "researchanddevelopmentlicensesacquiredexpensed": 95000,
    "sharebasedcompensation": 2495219,
    "marketablesecuritiesunrealizedgainloss": 3664,
    "increasedecreaseinprepaidexpense": 97716,
    "increasedecreaseinaccountspayable": 267357,
    "netcashprovidedbyusedinoperatingactivities": -4947215,
    "paymentstoacquiremarketablesecurities": 800000,
    "paymentstoacquireinprocessresearchanddevelopment": 95000,
    "netcashprovidedbyusedininvestingactivities": -895000,
    "proceedsfromissuanceofcommonstock": 5840167,
    "proceedsfromissuanceofcommonstockandwarrants": 1610130,
    "proceedsfromissuanceofwarrants": 163,
    "netcashprovidedbyusedinfinancingactivities": 7450460,
    "cashandcashequivalentsperiodincreasedecrease": 1608245,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 1890866,
    "conversionofpreferredstocktocommonstockuponcompletionofinitialpublicoffering": 310,
    "cashlesswarrantexercise": 22,
    "increasedecreaseinotheraccruedliabilities": 30484,
    "restrictedcash": 1657886,
    "restrictedcashequivalents": 200000,
    "restrictedcashandcashequivalents": 1857886,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 525000,
    "escrowdeposit": 200000,
    "numberofoperatingsegments": 1,
    "paymentsformilestone": 3500000,
    "proceedsfromstockoptionsexercised": 20000,
    "financingreceivablechangeinpresentvalueexpensereversal": 25000,
    "concentrationriskserviceprovided": "That director received $30,000 in cash compensation for services provided as a board member of the Company and $5,000 cash compensation for his services as a member of the Company’s Scientific Advisory Board. The Company also granted him options to purchase up to 35,000 of the Company’s common stock pursuant to the Company’s 2018 Equity Incentive Plan.",
    "deferredcompensationcashbasedarrangementsliabilitycurrent": 30000,
    "stockrepurchasedduringperiodshares": 35000,
    "dividendincomeoperating": 6947,
    "interestincomeoperating": 25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 13200,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 40000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 48330,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 4.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 5.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P4Y2M5D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.112,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0175,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 525000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 525000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 525000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 5.32,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 5.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 457250,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueissued": 457250,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 457250,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P5Y10M25D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualissued": "P9Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm1": "P9Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P9Y4M24D",
    "allocatedsharebasedcompensationexpense": 204550,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisedinperiodgross": -289830,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1032692,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisedinperiodweightedaverageexerciseprice": 0.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 2.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 3725745,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P4Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrants": 200000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 1,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 4000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P0Y9M18D",
    "preferredstockdesignated": 5000000,
    "preferredstockconvertedintocommonstock": 3102480,
    "preferredsharesremainauthorized": 1897520,
    "restrictedcommonstockofshares": 40000,
    "employeestockownershipplanesopcompensationexpense": 2500000,
    "leaseandrentalexpense": 32000,
    "deferredfederalincometaxexpensebenefit": 1692939,
    "deferredincometaxexpensebenefit": 1692939,
    "valuationallowancedeferredtaxassetchangeinamount": 1692939,
    "deferredtaxassetsoperatinglosscarryforwards": 1975501,
    "deferredtaxassetslicenseacquired": 133182,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 427558,
    "deferredtaxassetsnetcurrent": 2536241,
    "deferredincometaxassetsdepreciationfixedassets": 132,
    "totaldeferredincometax": 132,
    "deferredtaxassetsliabilitiesnet": 2536109,
    "deferredtaxassetsvaluationallowance": 2536109,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationreturntoprovision": -0.013,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": 0.004,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.22,
    "operatinglosscarryforwardsexpirationdate": "2037-12-31",
    "effectiveincometaxratecontinuingoperation": 0.8,
    "operatinglosscarryforwardslimitationsonuse": "1,500,000"
  }
]